QNCX - Quince Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.9 0.1 (5.26%)	---	0.0 (0.0%)	0.05 (2.56%)	0.0 (0.0%)	0.02 (0.77%)	0.05 (2.56%)	0.05 (2.56%)

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.34
Diluted EPS:: -0.34
Basic P/E:: -5.8824
Diluted P/E:: -5.8824
RSI(14) 1m:: 100.0
VWAP:: 1.99
RVol:: 0.3101

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.98 +0.03 (+1.28%)	Oct 15 15:58
1m	Price decrease 1m	1.94 -0.02 (-1.02%)	Oct 15 15:18
10m	Price decrease 10m	1.94 -0.06 (-3.0%)	Oct 15 15:17
1m	Price increase 1m	1.98 +0.02 (+1.11%)	Oct 15 15:08
1m	Price increase 1m	1.94 +0.02 (+1.04%)	Oct 15 14:27